Organon & Co. clinical trials

The registry lists 514 studies whose lead sponsor is Organon & Co. or one of 3 companies grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 514. Browse all 514 →

• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic DermatitisSuspendedNCT07265479Phase 3

  Sponsor listed in the registry: Organon and Co

• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related PainCompletedNCT05560646Phase 2

  Sponsor listed in the registry: Organon and Co

• Tapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsActive, not recruitingNCT05172726Phase 3

  Sponsor listed in the registry: Organon and Co

• An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)CompletedNCT00967746Phase 2

  Sponsor listed in the registry: Organon and Co

• A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)TerminatedNCT00651807Phase 2

  Sponsor listed in the registry: Organon and Co

• A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)CompletedNCT04626596Phase 3

  Sponsor listed in the registry: Organon and Co

• Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral ContraceptiveTerminatedNCT05264506Phase 3

  Sponsor listed in the registry: Organon and Co

• Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk PatientsCompletedNCT05761444Phase 4

  Sponsor listed in the registry: Organon and Co

• Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic DermatitisCompletedNCT05186805Phase 2

  Sponsor listed in the registry: Organon and Co

• Tapinarof for the Treatment of Atopic Dermatitis in Children and AdultsCompletedNCT05014568Phase 3

  Sponsor listed in the registry: Organon and Co

• Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)CompletedNCT05032859Phase 3

  Sponsor listed in the registry: Organon and Co

• Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic DermatitisCompletedNCT05142774Phase 3

  Sponsor listed in the registry: Organon and Co

• Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)CompletedNCT04053387Phase 3

  Sponsor listed in the registry: Organon and Co

• Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque PsoriasisCompletedNCT04042103Phase 2

  Sponsor listed in the registry: Organon and Co

• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)CompletedNCT03983980Phase 3

  Sponsor listed in the registry: Organon and Co

• A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck RegionCompletedNCT05789576Phase 4

  Sponsor listed in the registry: Organon and Co

• A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque PsoriasisCompletedNCT05680740Phase 4

  Sponsor listed in the registry: Organon and Co

• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)CompletedNCT03956355Phase 3

  Sponsor listed in the registry: Organon and Co

• A Study of E6005 in Japanese Patients With Atopic DermatitisCompletedNCT01179880Phase 1/2

  Sponsor listed in the registry: Organon and Co

• A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic DermatitisCompletedNCT02094235Phase 1/2

  Sponsor listed in the registry: Organon and Co

• A Phase 2 Study of E6005 in Patients With Atopic DermatitisCompletedNCT01461941Phase 2

  Sponsor listed in the registry: Organon and Co

• Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum HemorrhageCompletedNCT04364386Not applicable

  Sponsor listed in the registry: Alydia Health · First submitted before Alydia Health became part of Organon & Co.

• Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)CompletedNCT00703014

  Sponsor listed in the registry: Organon and Co

• Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)CompletedNCT00702273

  Sponsor listed in the registry: Organon and Co

• Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)CompletedNCT00702520

  Sponsor listed in the registry: Organon and Co

• A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)CompletedNCT01414192

  Sponsor listed in the registry: Organon and Co

• Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)CompletedNCT00702338

  Sponsor listed in the registry: Organon and Co

• Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)CompletedNCT00702234

  Sponsor listed in the registry: Organon and Co

• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)CompletedNCT00070707Phase 4

  Sponsor listed in the registry: Organon and Co

• A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)CompletedNCT01673620Phase 3

  Sponsor listed in the registry: Organon and Co

• Survey of Osteoarthritis Real World Therapies (MK-0663-140)CompletedNCT01294696

  Sponsor listed in the registry: Organon and Co

• A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)CompletedNCT00092651Phase 3

  Sponsor listed in the registry: Organon and Co

• A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)CompletedNCT00311844Phase 4

  Sponsor listed in the registry: Organon and Co

• Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)CompletedNCT00651560Phase 3

  Sponsor listed in the registry: Organon and Co

• Sitosterolemia Extension Study (0653-004)(COMPLETED)CompletedNCT00092820Phase 3

  Sponsor listed in the registry: Organon and Co

• A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)CompletedNCT00725374Phase 3

  Sponsor listed in the registry: Organon and Co

• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)CompletedNCT00651274Phase 4

  Sponsor listed in the registry: Organon and Co

• Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)CompletedNCT00380627Phase 4

  Sponsor listed in the registry: Organon and Co

• Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)CompletedNCT00431431Phase 4

  Sponsor listed in the registry: Organon and Co

• 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedNCT00143182Phase 3

  Sponsor listed in the registry: Organon and Co

• Elocon vs Fluticasone in Localized Psoriasis (P03197)CompletedNCT00763529Phase 4

  Sponsor listed in the registry: Organon and Co

• MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)CompletedNCT00771160Phase 3

  Sponsor listed in the registry: Organon and Co

• An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedNCT00878462Phase 2

  Sponsor listed in the registry: Organon and Co

• Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)CompletedNCT00757562Phase 3

  Sponsor listed in the registry: Organon and Co

• MD Ezetimibe Cyclosporine Interaction (0653-057)CompletedNCT00653276Phase 1

  Sponsor listed in the registry: Organon and Co

• An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)CompletedNCT00076973Phase 3

  Sponsor listed in the registry: Organon and Co

• Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)CompletedNCT00251576Phase 3

  Sponsor listed in the registry: Organon and Co

• An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)CompletedNCT00092729Phase 3

  Sponsor listed in the registry: Organon and Co

• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)CompletedNCT00092573Phase 3

  Sponsor listed in the registry: Organon and Co

• Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)CompletedNCT00867191Phase 4

  Sponsor listed in the registry: Organon and Co